B.Pharmacy

Hyperemesis gravidarum: Complications and Management

Auxi Arobana. R, Clinical pharmacy, Pharmacology, Pharmacy Practice

What is hyperemesis gravidarum? Hyperemesis gravidarum refers to the extreme and stubborn vomiting during pregnancy. This post focuses on the key features, causes, risk factors, diagnosis, complications and management of hyperemesis gravidarum. Nausea and vomiting during pregnancy is a common problem during the first trimester of pregnancy. Nausea and emesis during pregnancy usually subside after […]

Hyperemesis gravidarum: Complications and Management Read More »

Otitis media/ Middle ear infection

Auxi Arobana. R, Clinical pharmacy, Pathophysiology, Pharmacology, Pharmacy Practice

What is otitis media or middle ear infection? Otitis media (OM)/middle ear infection/ acute otitis media refers to the inflammation (mostly due to infection) of the middle ear. Otitis media (OM) sums up a spectrum of diseases including OM is caused due to various factors and is more common in children (6-24 months of age).

Otitis media/ Middle ear infection Read More »

Antimicrobial resistance : Causes, Complications & Prevention

Auxi Arobana. R, Clinical pharmacy, Pharmaceutical Microbiology, Pharmacology, Pharmacy Practice

Antimicrobial resistance Antimicrobial resistance occurs when the antimicrobial agent (antibiotics, anti-viral, antifungal, antiprotozoal) which was used to treat the diseases caused by a microorganism (bacteria, fungi, virus, protozoa) become ineffective in killing or reducing the growth of the microorganism. The microorganism develops new mechanisms that will protect them from the effect of the drug/ antimicrobials.

Antimicrobial resistance : Causes, Complications & Prevention Read More »

ORPHAN DRUGS: THE OUTCASTS OF THE PILL WORLD

Health, Pharmaceutical Marketing

What are orphan drugs? Certain diseases are very rare and if we need to research, develop and market drugs for such rare diseases the cost or expenses that occurs will be unrecoverable by the manufacturer or pharmaceutical company from selling these drugs. Such drugs are called as orphan drugs. A drug is said to be

ORPHAN DRUGS: THE OUTCASTS OF THE PILL WORLD Read More »

THERANOSTICS: A PROMISING RAY IN CANCER TREATMENT

Pharmaceutical Technology / 1 Comment

What is Theranostics? Theranostics, as the name implies, is a blend of diagnostics and therapeutics. filmed by US consultant John Funkhouser in 1998. Theranostics explain developments in science.[1] Theranostics play a significant role in providing cost-effective treatment plans and are highly efficient in specific medicine protocols. To be more precise, theranostics in combination with nanoscience

THERANOSTICS: A PROMISING RAY IN CANCER TREATMENT Read More »

Machine Learning in the Hunt for New Bacterial and Fungal Strains

Pharmaceutical Microbiology / 1 Comment

The microscopic world of bacteria and fungi holds a universe of diversity, with countless strains. These novel strains can be crucial for scientific advancements, from developing new antibiotics to understanding the ecology of our planet. Traditionally, identifying new strains has relied on laborious and time-consuming techniques. However, machine learning (ML) is emerging as a powerful

Machine Learning in the Hunt for New Bacterial and Fungal Strains Read More »

Smarter Diagnosis Faster Treatment: AI

Pharmaceutical Microbiology / 1 Comment

Infectious diseases have plagued humanity for centuries. Fortunately, the future of battling these illnesses is looking brighter thanks to Artificial Intelligence (AI). AI has the potential to revolutionize how we diagnose and treat infections, leading to faster identifications, personalized therapies, and a healthier tomorrow. Smarter Diagnosis, Faster Treatment: AI Transforming Infectious Disease Diagnosis: AI AI:

Smarter Diagnosis Faster Treatment: AI Read More »